STAHN; Renate

Patent Applications and Registrations

Patent applications and USPTO patent grants for STAHN; Renate.The latest application filed is for "use of human cells of myeloid leukaemia origin for expression of antibodies".

Company Profile

2.12.10

STAHN; Renate - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Human Cells Of Myeloid Leukaemia Origin For Expression Of Antibodies App 20190359731 - GOLETZ; Steffen ; et al.	2019-11-28
Use of human cells of myeloid leukemia origin for expression of antibodies Grant 10,280,230 - Goletz , et al.	2019-05-07
Recognition molecules for the treatment and detection of tumors Grant 9,845,361 - Goletz , et al. December 19, 2	2017-12-19
Tumor-specific recognition molecules Grant 9,345,794 - Goletz , et al. May 24, 2	2016-05-24
Use Of Human Cells Of Myeloid Leukaemia Origin For Expression Of Antibodies App 20150368363 - GOLETZ; Steffen ; et al.	2015-12-24
MUC1 antibodies Grant 9,217,038 - Goletz , et al. December 22, 2	2015-12-22
Use of human cells of myeloid leukaemia origin for expression of antibodies Grant 9,051,356 - Goletz , et al. June 9, 2	2015-06-09
Recognition Molecules For The Treatment And Detection Of Tumors App 20150005474 - Goletz; Steffen ; et al.	2015-01-01
Recognition molecules for the treatment and detection of tumors Grant 8,779,102 - Goletz , et al. July 15, 2	2014-07-15
Tumor-specific Recognition Molecules App 20140099259 - Goletz; Steffen ; et al.	2014-04-10
Tumor-specific recognition molecules Grant 8,617,846 - Goletz , et al. December 31, 2	2013-12-31
Tumor-specific Recognition Molecules App 20120149877 - Goletz; Steffen ; et al.	2012-06-14
Muc1 Antibodies App 20120128676 - Goletz; Steffen ; et al.	2012-05-24
Tumor-specific recognition molecules Grant 8,088,357 - Goletz , et al. January 3, 2	2012-01-03
Use Of Human Cells Of Myeloid Leukaemia Origin For Expression Of Antibodies App 20100028947 - Goletz; Steffen ; et al.	2010-02-04
Recognition molecules for the treatment and detection of tumours App 20060292643 - Goletz; Steffen ; et al.	2006-12-28
Tumor-specific recognition molecules App 20060251668 - Goletz; Steffen ; et al.	2006-11-09
Use of selectin-binding pregnancy proteins, liposomes, native mucin fragments and mimetic compounds for the treatment and prophylaxis inflammatory diseases, for preventing metastatic spread and for the prophylaxis of tumour diseases App 20040191303 - Stahn, Renate ; et al.	2004-09-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.